Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence

Kaplan, J., Askanase, A., Chu, D., Abdellatif, A., Basu, D., & Mirsaeidi, M. (2023). Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence. Clinical Drug Investigation, 43(10), 739–761. https://doi.org/10.1007/s40261-023-01303-5
Authors:
Jeffrey Kaplan
Anca Askanase
David Chu
Abdul Abdellatif
Dhiman Basu
Mehdi Mirsaeidi
Affiliated Authors:
Anca Askanase
Columbia Affiliation:
Subjects:
Multiple Sclerosis (MeSH)
Lupus Erythematosus, Systemic (MeSH)
Arthritis, Rheumatoid (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1007/s40261-023-01303-5
PMID:
37792273
DOI:
10.1007/s40261-023-01303-5
Journal:
Clinical Drug Investigation
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: